Multicenter Phase III Study of Gefitinib Mono-therapy or Gefitinib Combined With Chemotherapy in Patients With Brain Metastases From Non-small Cell Lung Cancer Harboring EGFR Mutation
Latest Information Update: 07 Feb 2024
At a glance
- Drugs Gefitinib (Primary) ; Cisplatin; Pemetrexed
- Indications Brain metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 07 Jun 2022 Primary endpoint (iPFS(intracranial progression free survival) has been met, according to Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology.
- 07 Jun 2022 Status changed from recruiting to active, no longer recruiting, according to Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology.
- 07 Jun 2022 Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology.